Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

WINTHROP K. L., PARK S., Gül A., CARDIEL M. H., GOMEZ-REINO J. J., TANAKA Y., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.75, sa.6, ss.1133-1138, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1136/annrheumdis-2015-207319
  • Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1133-1138
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objectives To evaluate the risk of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with tofacitinib.